Definium Therapeutics, Inc.

DFTX ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
4	Sep 29, 2026	OWNERSHIP DOCUMENT
4	Sep 29, 2026	OWNERSHIP DOCUMENT
4	Sep 29, 2026	OWNERSHIP DOCUMENT
4	Sep 29, 2026	OWNERSHIP DOCUMENT
4	Sep 29, 2026	OWNERSHIP DOCUMENT
144	Sep 25, 2026
144	Sep 25, 2026
144	Sep 25, 2026
144	Sep 25, 2026
144	Sep 25, 2026
4	Sep 18, 2026	4
4	Sep 18, 2026	4
4	Sep 14, 2026	4
4	Sep 14, 2026	4
4	Sep 14, 2026	4
4	Sep 14, 2026	4
4	Sep 14, 2026	4
8-K	Sep 14, 2026	FORM 8-K
8-K	Sep 8, 2026	8-K
4	Sep 4, 2026	4
144	Sep 3, 2026
SCHEDULE 13G/A	Aug 14, 2026
SCHEDULE 13G/A	Aug 14, 2026
4	Aug 12, 2026	4
4	Aug 12, 2026	4

← Newer Page 1 of 21 · 503 filings Older →